Patent US5549601A successfully refreshed from Google Patents.
US5549601A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Delivery of intracorporeal probes
Assignee: Abbott Cardiovascular Systems Inc
•
Filing: 1994-10-11
•
Granted: 1996-08-27
•
Expires: 2014-10-11
Abstract
Abstract A system for delivering a probe into a body part to perform a therapeutic or diagnostic procedure therein which includes an elongated probe device which is disposed within a protective sheath and which has a rotary drive unit connected to its proximal extremity to rotate the probe about its longitudinal axis, preferably at a rate above 50 rpms while applying axial pressure thereto to cause the distal end of the probe to penetrate through the patient's tissue to a desired location in the body part where the procedure is to occur. In a presently preferred embodiment, the probe is an optical fiber which is delivered into a male patient's prostate gland through the patient's prostatic urethral wall. The optical fiber is optically connected to a source for laser energy (815 nm) which is emitted from the distal end of the optical fiber to ablate prostatic tissue surrounding the distal end. A sheath is disposed about the optical fiber to support the shaft thereof and to minimize damage to the working channel of a cystoscope through which the device is usually advanced to reach the desired location within the patient's prostatic urethra.
Inventors
- 👤 John McIntyre
- 👤 Peter S. Brown
- 👤 Stephen A. Morse
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 18:07
CPC Classifications
A; A61; A61B; A61B18/00; A61B18/18; A61B18/20; A61B18/22; A61B18/24; A61B17/00; A61B17/32; A61B17/3205; A61B17/3207; A61B17/320758; A61B17/00234; A61B2017/00238; A61B2017/00274; A61B2017/00831; A61B2017/0084; A61B17/22; A61B2017/22072; A61B2017/22074; A61B2017/22077; A61B2017/22078; A61B2018/00315; A61B2018/00547; A61B90/00; A61B90/36; A61B90/361
Claims Analysis
Total Claims: 18
Claim 1
Independent Claim
141 words
A method of performing a therapeutic or diagnostic procedure within a patient, comprising: a) providing an therapeutic or diagnostic assembly which includes an outer sheath having an inner lumen and a open distal end and an elongated optical fiber device having a distal end configured to emit laser energy, being slidably disposed within the inner lumen of the outer sheath and extending out the open distal end of the outer sheath; b) urging the distal end of the optical fiber device against tissue to be penetrated while the device is rotated within the outer sheath to place the distal end of the device at a location within the patient where the therapeutic or diagnostic procedure is to be performed; and c) directing laser energy through the optical fiber device and out the distal end thereof at the location in the patient.
Claim 2
Independent Claim
141 words
A method of performing a therapeutic or diagnostic procedure within a patient, comprising: a) providing an therapeutic or diagnostic assembly which includes an outer sheath having an inner lumen and a open distal end and an elongated optical fiber device having a distal end configured to emit laser energy, being slidably disposed within the inner lumen of the outer sheath and extending out the open distal end of the outer sheath; b) urging the distal end of the optical fiber device against tissue to be penetrated while the device is rotated within the outer sheath to place the distal end of the device at a location within the patient where the therapeutic or diagnostic procedure is to be performed; and c) directing laser energy through the optical fiber device and out the distal end thereof at the location in the patient.
Claim 3
Dependent Claim
20 words
The method of claim 1 wherein the optical fiber device is rotated at a speed of at least 50 rpms.
Claim 4
Dependent Claim
23 words
The method of claim 1 wherein the optical fiber device is rotated at a rotational speed of about 200 to about 3000 rpms.
Claim 5
Dependent Claim
26 words
The method of claim 1 wherein the optical fiber device has a proximal end configured to engage a laser energy source in a light transmitting relationship.
Claim 6
Dependent Claim
26 words
The method of claim 1 wherein the therapeutic or diagnostic assembly is advanced through a working channel of an endoscope disposed within a patient's body lumen.
Claim 7
Dependent Claim
27 words
The method of claim 5 wherein the endoscope has a deflectable distal end which guides the therapeutic or diagnostic assembly to the desired tissue to be penetrated.
Claim 8
Independent Claim
129 words
A system for debulking a patient's prostate gland, comprising: a) a protective sheath having an inner lumen extending therein which is configured to be slidably disposed within a working lumen of a cystoscope; b) an elongated optical fiber having a proximal end and a distal end and being slidably disposed within the inner lumen of the protective sheath; c) a laser energy source in light transmitting relationship with the proximal end of the optical fiber to deliver laser energy thereto; and d) rotary drive means to rotate the optical fiber at a rate greater than about 50 revolutions per minute while an axial force is applied to the optical fiber to facilitate penetration by the distal end of the optical fiber through the prostatic urethra into the prostate gland.
Claim 9
Independent Claim
129 words
A system for debulking a patient's prostate gland, comprising: a) a protective sheath having an inner lumen extending therein which is configured to be slidably disposed within a working lumen of a cystoscope; b) an elongated optical fiber having a proximal end and a distal end and being slidably disposed within the inner lumen of the protective sheath; c) a laser energy source in light transmitting relationship with the proximal end of the optical fiber to deliver laser energy thereto; and d) rotary drive means to rotate the optical fiber at a rate greater than about 50 revolutions per minute while an axial force is applied to the optical fiber to facilitate penetration by the distal end of the optical fiber through the prostatic urethra into the prostate gland.
Claim 10
Dependent Claim
54 words
The system of claim 7 including a urethral cystoscope having at least one working lumen extending therein and being configured to be advanced through a male patient's urethral canal to the patient's prostatic urethra within the patient's prostate gland with the sheath and the optical fiber disposed therein slidably disposed within the working lumen.
Claim 11
Dependent Claim
41 words
The system of claim 8 wherein the cystoscope has a flexible shaft and means operable from the proximal end thereof to deflect the distal end of the cystoscope to guide the optical fiber to a desired region of the prostatic urethra.
Claim 12
Dependent Claim
19 words
The system of claim 7 wherein the optical fiber has a diameter of about 400 to about 800 microns.
Claim 13
Dependent Claim
17 words
The system of claim 7 wherein the optical fiber has a lubricous coating on the exterior thereof.
Claim 14
Independent Claim
122 words
A method for treating a male patient for benign prostatic hyperplasia comprising: a) advancing an optical fiber having proximal and distal ends through a patient's urethra until the distal end is disposed within a desired portion of the patient's prostatic urethra; b) pressing the distal end of the optical fiber against a wall of the patient's prostatic urethra and rotating the optical fiber until the distal end of the optical fiber passes through the wall of the prostatic urethra into a desired region of the patient's prostate gland adjacent the wall; and c) directing laser energy from a source thereof through the optical fiber and out the distal end thereof to ablate prostatic tissue adjacent the distal end of the optical fiber.
Claim 15
Independent Claim
122 words
A method for treating a male patient for benign prostatic hyperplasia comprising: a) advancing an optical fiber having proximal and distal ends through a patient's urethra until the distal end is disposed within a desired portion of the patient's prostatic urethra; b) pressing the distal end of the optical fiber against a wall of the patient's prostatic urethra and rotating the optical fiber until the distal end of the optical fiber passes through the wall of the prostatic urethra into a desired region of the patient's prostate gland adjacent the wall; and c) directing laser energy from a source thereof through the optical fiber and out the distal end thereof to ablate prostatic tissue adjacent the distal end of the optical fiber.
Claim 16
Dependent Claim
16 words
The method of claim 12 wherein the optical fiber is rotated at more than 50 rpms.
Claim 17
Dependent Claim
18 words
The method of claim 12 wherein the optical fiber is rotated at about 200 to about 3000 rpms.
Claim 18
Dependent Claim
26 words
The method of claim 12 wherein the laser energy directed out the distal end of the optical fiber has a wave length of about 815 nanometers.
References Cited (Backward Citations)
US3433226A
Cited
US3352303A
Cited
US4223676A
Cited
US4445509A
Cited
US5090956A
Cited
US4732154A
Cited
US4646736A
Cited
US4990134A
Cited
US4990134B1
Cited
US4749376A
Cited
EP0268228A2
Cited
US4923462A
Cited
US4798586A
Cited
US4854325A
Cited
US5344395A
Cited
EP0452631A1
Cited
EP0465449A2
Cited
US5188634A
Cited
US5267954A
Cited
US5324255A
Cited
US5304115A
Cited
US5326342A
Cited
US5312328A
Cited
US5151096A
Cited
US5345940A
Cited
US5330465A
Cited
US5290279A
Cited
US5383859A
Cited
US5312392A
Cited
US5243997A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1999-08-27 | 2000-02-26 | 2000-08-27 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2003-08-27 | 2004-02-26 | 2004-08-27 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2007-08-27 | 2008-02-26 | 2008-08-27 | $7700.00 | Window Closed / Lapsed |